Casey C. Kopczynski
Geen lopende functies
Loopbaan van Casey C. Kopczynski
Eerdere bekende functies van Casey C. Kopczynski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 22-06-2005 | 01-03-2022 |
| Oprichter | 22-06-2005 | 21-11-2022 | |
| Corporate Officer/Principal | 01-03-2022 | 21-11-2022 | |
| Biotech Initiative LLC | Corporate Officer/Principal | 01-01-2002 | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Hoofd Techniek/Wetenschap/O&O | 01-01-2003 | - |
| EXELIXIS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1996 | 01-01-2002 |
Opleiding van Casey C. Kopczynski
| Indiana University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
| Biotech Initiative LLC |
- Beurs
- Insiders
- Casey C. Kopczynski
- Ervaring
